An underground market for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Experimental Treatment Gaining Popularity Online
The experimental drug, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.
Active Commerce on Social Networks
Separately, a robust market exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day UK delivery. Sellers market the substance there before directing customers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Experts Express Concerns
However, physicians and chemists have cautions that the distribution of what remains an unapproved drug in the United Kingdom is worrisome and could result in users injecting products of unknown origin.
Several experts stated the demand for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the British medical regulations.
Several influencers try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate medicines, marketing, and consumer regulations, risking penalties, prosecution or prison.
Service Reaction and Material Removal
According to TikTok, the platform has removed violative content and prohibited associated hashtags and search suggestions. The organization stated it was dedicated to maintaining the platform secure and allocating resources in enhancing enforcement strategies.
Online Trading Activities
Research also discovered groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly displays groups with thousands of members, populated with images of slimming results, positive testimonials and step-by-step instructions for preparing or injecting at residence.
Within minutes of entering one community, a seller shared contact information, where most transactions occur. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, health issues or past usage.
Product Information and Costs
Inside these communities, posts show dark colored packages with postal service stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20mg. When asked how much time a injector should last, vendors give conflicting responses varying between a several days to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for Telegram stated it actively monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.
Her team has already encountered patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may expose users to potentially significant health risks”.
